GR
GRX.US Gabelli Healthcare & WellnessRx Trust
- Market cap
- USD 151M
- P/E
- 18.3x
- P/B
- 0.99x
- ROE
- 11.4%
- Dividend yield
- 6.70%
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is GRX.US undervalued?
Graham numberGRX.US trades 10.4% below its Graham number.
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Gabelli Healthcare & WellnessRx Trust fundamental analysis
No fundamental analysis for Gabelli Healthcare & WellnessRx Trust yet.
Gabelli Healthcare & WellnessRx Trust stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Gabelli Healthcare & WellnessRx Trust
The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Con…
Full company profileGabelli Healthcare & WellnessRx Trust financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Gabelli Healthcare & WellnessRx Trust annual financial statements (USD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2008 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 898K | 32.5M | -1.53M | 53.8M | 25.0M | 43.5M | -46.7M | 4.01M | 3.26M | 15.3M | 31.2M |
| Gross Profit | 52.7K | 32.5M | -1.53M | 53.8M | 25.0M | 43.5M | -46.7M | 1.24M | 343K | 12.8M | 26.1M |
| Operating Income | -576K | 31.7M | -2.28M | 53.2M | 24.2M | 42.7M | -44.3M | 3.20M | 2.68M | 4.74M | 24.8M |
| EBITDA | - | 31.7M | -2.28M | 53.2M | 24.2M | 42.7M | -44.3M | 3.20M | 2.68M | 4.77M | 24.8M |
| Net Income | -15.0M | 31.7M | -2.28M | 53.2M | 24.2M | 42.7M | -47.4M | 423K | -285K | 2.29M | 17.5M |
| EPS | - | 1.82 | -0.12 | 2.89 | 1.38 | 2.48 | -2.78 | 0.03 | -0.02 | 0.15 | 1.20 |
| Balance Sheet | |||||||||||
| Total Assets | 53.5M | 301M | 272M | 307M | 286M | 351M | 249M | 239M | 226M | 242M | 229M |
| Total Liabilities | 830K | 1.08M | 688K | 571K | 44.3M | 86.9M | 44.0M | 54.2M | 54.9M | 83.4M | 75.9M |
| Shareholders' Equity | 52.6M | 300M | 272M | 306M | 242M | 264M | 205M | 185M | 171M | 159M | 153M |
| Cash & Short-term Investments | 722.00 | - | 6.27K | - | 11.8K | - | 50.5K | 2.37K | - | 18.0K | 2.12K |
| Total Debt | - | - | 120.00 | - | 40.0M | 80.1M | 40.0M | 53.3M | 10.1K | 70.7M | 69.8M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -15.0M | - | - | - | 45.2M | -18.9M | 58.1M | -356K | -2.33M | 9.43M | -34.2M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 3.00 | 0.00 | 3.00 | 4.00 | 3.00 | 12.00 |
| Free Cash Flow | - | - | - | - | 45.2M | -18.9M | 58.1M | -356K | 13.1M | 9.43M | -34.2M |
| Ratios | |||||||||||
| ROE | -28.6% | 10.6% | -0.8% | 17.4% | 10.0% | 16.2% | -23.2% | 0.2% | -0.2% | 1.4% | 11.4% |
| ROA | -28.1% | 10.5% | -0.8% | 17.3% | 8.4% | 12.2% | -19.1% | 0.2% | -0.1% | 0.9% | 7.6% |
| Net Profit Margin | -1,672.4% | 97.5% | - | 98.9% | 96.7% | 98.3% | - | 10.5% | -8.7% | 15.0% | 56.1% |
| Debt to Equity | - | - | 0.00x | - | 0.17x | 0.30x | 0.20x | 0.29x | 0.00x | 0.45x | 0.46x |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Gabelli Healthcare & WellnessRx Trust dividends
- Dividend yield
- 6.70%
- Forward dividend
- 0.80 USD
- Payout ratio
- 442.3%
- Ex-dividend date
- Dec 11, 2026
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2025 | USD 10.1M | 0.66 | 442.3% |
| 2024 | USD 9.37M | 0.60 | - |
| 2023 | USD 9.94M | 0.62 | 2,350.4% |
| 2022 | USD 16.5M | 0.97 | - |
| 2021 | USD 16.5M | 0.96 | 38.7% |
| 2020 | USD 10.4M | 0.59 | 43.1% |
| 2019 | - | - | - |
| 2018 | - | - | - |
| 2017 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1035:1000 on May 30, 2014.
Who owns Gabelli Healthcare & WellnessRx Trust
- Insiders 1.77%
- Institutions 42.02%
- Public & others 56.21%
- Shares outstanding 14.5M
Gabelli Healthcare & WellnessRx Trust company profile
- Company name
- Gabelli Healthcare & WellnessRx Trust
- Ticker
- GRX.US
- Exchange
- USA Stocks
- Listed since
- Jun 19, 2007
- Sector
- Financial Services
- Industry
- Capital Markets
- Fiscal year end
- December
- Address
- One Corporate Center, Rye, NY, United States, 10580-1422
- Phone
- 914-921-5000
About Gabelli Healthcare & WellnessRx Trust
The Gabelli Healthcare & Wellness Trust is a closed-ended equity mutual fund launched by GAMCO Investors, Inc. The fund is managed by Gabelli Funds, LLC. It invests in the public equity markets across the globe. The fund seeks to invest in stocks of companies primarily operating in the healthcare and wellness sector. It invests in stocks of companies across all market capitalizations. The fund benchmarks the performance of its portfolio against the S&P 500 Index, S&P 500 Consumer Staples Index, and S&P 500 Health Care Index. The Gabelli Healthcare & Wellness Trust was formed on February 20, 2007 and is domiciled in the United States.
Gabelli Healthcare & WellnessRx Trust management
8- Mr. Wayne Christopher Pinsent C.F.A.Assistant Vice President and Ombudsman · born 1986
- Mr. Mario Joseph Gabelli C.F.A.Portfolio Manager · born 1942
- Mr. Bruce N. Alpert CPAExecutive Vice President & Chief Operating Officer · born 1952
- Mr. Adam E. TokarVice President · born 1980
- Mr. Carter W. AustinSenior Vice President · born 1966
- Mr. David I. SchachterVice President · born 1953
- Mr. Kevin V. DreyerPortfolio Manager
- Mr. Jeffrey J. Jonas Jr., C.F.A., Jr.Portfolio Manager